CEL-SCI Co. (NYSEMKT:CVM) is set to release its earnings data after the market closes on Tuesday, August 8th.
CEL-SCI (NYSEMKT:CVM) last released its quarterly earnings data on Wednesday, May 10th. The company reported ($0.05) earnings per share for the quarter. CEL-SCI had a negative return on equity of 4,970.98% and a negative net margin of 48,949.30%. The business had revenue of $0.02 million for the quarter. On average, analysts expect CEL-SCI to post $-0.42 EPS for the current fiscal year and $-0.29 EPS for the next fiscal year.
CEL-SCI Co. (NYSEMKT:CVM) opened at 2.15 on Tuesday. The firm’s 50-day moving average is $1.97 and its 200 day moving average is $0.58. CEL-SCI Co. has a 12-month low of $0.06 and a 12-month high of $2.95. The firm’s market cap is $19.76 million.
CEL-SCI Company Profile
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.
Receive News & Ratings for CEL-SCI Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI Co. and related companies with MarketBeat.com's FREE daily email newsletter.
